Anti-Mllerian hormone (AMH) is a glycoprotein hormone produced by granulosa cells in ovarian follicles. The level of AMH in a woman’s blood is often used as an indicator of ovarian reserve, which refers to the quantity and quality of a woman’s remaining eggs. Consequently, strategies aimed at positively influencing AMH levels are often explored, especially in the context of fertility concerns. However, it’s important to clarify that interventions typically focus on optimizing conditions that support healthy ovarian function, rather than directly increasing AMH production itself. For instance, lifestyle modifications, such as maintaining a healthy weight and reducing stress, are often considered.
AMH levels are a valuable tool for assessing reproductive potential, particularly in women planning for pregnancy or undergoing fertility treatments like in vitro fertilization (IVF). While a high AMH level generally indicates a larger ovarian reserve, a low level can suggest diminished ovarian reserve, potentially impacting fertility. Understanding factors that influence or are associated with AMH is crucial for informed reproductive health decisions. Historically, research focused on identifying the causes of declining AMH and developing strategies to mitigate the impact of low AMH on fertility outcomes.
